ArticleAnnals of medicine and surgery (2012)2026

Commentary on PURPOSE-1 and PURPOSE-2 trials of lenacapavir: a breakthrough in HIV prevention.

Mustabshira Idrees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.